Company news

Invex Therapeutics Ltd. news in 2020

Invex Therapeutics Ltd.'s news releases, calls and decks from 2020, newest first.

View company

Invex Successfully Concludes Protocol Assistance with EMA

December 22, 2020

Chairmans Address to Shareholders and Presentation

November 18, 2020

Investor Presentation

November 4, 2020

Invex Provides Development Update

October 30, 2020

Quarterly Report and Appendix 4C with appendix

August 7, 2020

Quarterly Report and Appendix 4C

July 23, 2020

Initial FDA and EMA Advice on Presendin Development

July 22, 2020

Notice of Allowance for Key US Exenatide Patent

July 20, 2020

Phase II Clinical Results and Capital Raising Presentation

May 22, 2020

Succesful $26 million Share Placement

May 22, 2020

Exenatide Meets Key Endpoints in IIH Clinical Trial

May 19, 2020

Appendix 4D and Half-year Report

February 26, 2020

Decks in 2020